Sucampo Pharmaceuticals 2017 Form 8-K Current Report

Sucampo Pharmaceuticals reported Q4 and full-year 2016 financial results on March 8, 2017. The filing also documents executive transitions, including the departure of CFO Andrew Smith and the appointment of Peter Pfreundschuh, CPA, as Chief Financial Officer effective March 20, 2017.